Ad hoc publication
EMCDDA Trendspotter briefing: impact of COVID-19 on patterns of drug use and drug-related harms in Europe
Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of this pandemic for people who use drugs in Europe, the EMCDDA instigated a mixed-...
Ad hoc publication
EMCDDA trendspotter briefing - Impact of COVID-19 on drug services and help-seeking in Europe
Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of this outbreak for drug services in Europe, the European Monitoring Centre for...
Evidence database of the Best practice portal
This database presents the latest evidence on drug-related interventions. The information is based on systematic searches is updated twice a year. Topics covered include harm reduction, social reintegration, treatment, prevention as well as emerging topics.
Health and social responses to drug problems: a European guide
This guide and the associated package of online materials provides a reference point for planning or delivering health and social responses to drug problems in Europe. The most appropriate responses will depend on the specific drug problems, the contexts in which these occur and the types of...
Co-morbid substance use and mental disorders in Europe: a review of the data
Summary: Identifying the co-occurrence of drug use and mental health disorders in the same individuals is essential for effective treatment of their drug use problems. Reviewing the available information on psychiatric co-morbidity among drug users in European countries, the paper shows that there...
Drugs in focus
Comorbidity — drug use and mental disorders
Comorbidity is often underestimated and underdiagnosed. Two main groups of comorbid drug users are recognised, each with distinct profiles. One group is dominated by people with psychiatric illness and the second group is characterised by drug dependency.